This statistic displays the share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013. The share of GDP expenditure on pharmaceuticals and other medical non-durables reached 1.88 percent in 2009.
Share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic GDP expenditure on pharmaceuticals and medical non-durables in Hungary 2005-2015
- Premium Statistic GDP expenditure on pharmaceuticals and medical non-durables in Germany 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in the Netherlands
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Bulgaria 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Germany 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Portugal 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Greece 2005-2015
- Premium Statistic GDP expenditure on pharmaceuticals and other medical non-durables in Poland 2005-2015
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Hungary 2005-2015
- Premium Statistic GDP expenditure on pharmaceuticals and other medical non-durables in Bulgaria 2005-15
About the region
10
- Premium Statistic GDP expenditure on out-patient curative and rehabilitative care in France 2003-2013
- Basic Statistic Production value of pharmaceutical products & preparations in France 2012-2021
- Basic Statistic Turnover of the manufacture of pharmaceutical products in France 2013-2022
- Basic Statistic France: monthly consumer price index for health 2021
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Premium Statistic Pharmaceutical products: wholesale value growth rate France 2005-2019
- Premium Statistic Number of men covered for mental disability in France 2018, by age group
- Premium Statistic Health insurance expenditure for mental deficiency in France 2018, by type
- Premium Statistic Number of people covered for mental disability in France 2018, by region
- Premium Statistic Number of people covered for mental disability in France 2018, by age group
Other regions
10
- Premium Statistic Health expenditure on pharmaceuticals and medical non-durables in Romania 2005-2015
- Premium Statistic Expenditure for self-medication products in Italy 2013-2022
- Premium Statistic Predicted oncology spending in 2023, by region
- Basic Statistic U.S. health care spending growth 2010-2019, by sector
- Premium Statistic Spending on pharmaceuticals in the United Kingdom (UK) 2003-2014
- Premium Statistic Leading pharmaceutical companies in Norway 2021, by market share
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Number of employees at LEO Pharma 2009-2023
- Premium Statistic Drug production value of cardiovascular agents Japan 2022, by category
- Basic Statistic Total public drug program spending in Canada by therapy 2022
Related statistics
10
- Basic Statistic Hospital drug spending in Canada by province 2018
- Basic Statistic Share of drug spending in hospitals in Canada by province 2018
- Basic Statistic Top drugs by community hospital spending in the U.S. 2017
- Basic Statistic Per unit price of top drugs by community hospital spending in the U.S. 2017
- Premium Statistic Hospital beds in Bulgaria 2010-2021
- Premium Statistic Number of scientific, therapeutic and technical staff in the NHS in England 2004-2022
- Premium Statistic Value added by U.S. hospitals 2017-2022
- Basic Statistic Nursing care facilities expenditure in the U.S. 1960-2022
- Premium Statistic Number of hospitals in Canada by province and employer status 2022
- Premium Statistic Number of hospitals in Canada by province and employment size 2021
Further related statistics
10
- Medicaid long-term care services expenditures by type of service 1990-21
- Key figures on established biotech centers worldwide 2012-2016
- Global pharmaceutical pipeline by therapy area 2013-2017
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Location of death among hospice patients in the U.S. 2018
- Size of U.S. hospices by number of admissions 2012-2014
- Expenditure worldwide on diabetes by market 2013-2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Further Content: You might find this interesting as well
Statistics
- Medicaid long-term care services expenditures by type of service 1990-21
- Key figures on established biotech centers worldwide 2012-2016
- Global pharmaceutical pipeline by therapy area 2013-2017
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Location of death among hospice patients in the U.S. 2018
- Size of U.S. hospices by number of admissions 2012-2014
- Expenditure worldwide on diabetes by market 2013-2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's revenue from top product Pulmicort 2006-2023
European Commission. (October 24, 2016). Share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013 [Graph]. In Statista. Retrieved April 25, 2024, from https://www.statista.com/statistics/671058/gdp-expenditure-on-pharmaeuticals-in-france/
European Commission. "Share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013." Chart. October 24, 2016. Statista. Accessed April 25, 2024. https://www.statista.com/statistics/671058/gdp-expenditure-on-pharmaeuticals-in-france/
European Commission. (2016). Share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013. Statista. Statista Inc.. Accessed: April 25, 2024. https://www.statista.com/statistics/671058/gdp-expenditure-on-pharmaeuticals-in-france/
European Commission. "Share of Gdp Expenditure on Pharmaceuticals and Other Medical Non-durables in France from 2003 to 2013." Statista, Statista Inc., 24 Oct 2016, https://www.statista.com/statistics/671058/gdp-expenditure-on-pharmaeuticals-in-france/
European Commission, Share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013 Statista, https://www.statista.com/statistics/671058/gdp-expenditure-on-pharmaeuticals-in-france/ (last visited April 25, 2024)
Share of GDP expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013 [Graph], European Commission, October 24, 2016. [Online]. Available: https://www.statista.com/statistics/671058/gdp-expenditure-on-pharmaeuticals-in-france/